The BBB represents a dynamic boundary that impedes the entry of blood borne pathogens, toxic plasma components, blood cells and toxic chemicals into the brain, allowing at the same time selective passive transport of nutrients and metabolites (Obermeier et al., 2013)
The quality of the underlying material determines whether any of that arithmetic means anything
A controlled dose-response trial like this one is useful background for labeling and consumer-protection conversations, even though it cannot verify what any individual retail product actually contains
FDA says cost, convenience, and supply preference do not create a 503B clinical need. Patients should not treat compounded GLP-1 products as FDA-approved generics
In summary, our results show that semaglutide was associated with a lower risk for both incident and relapse of CUD compared to non-GLP-1 RA anti-obesity and anti-diabetes medications
Injection site reactions Redness, itching, swelling, and minor bruising occur in approximately 1.4% of semaglutide users and 2.4% of tirzepatide users